Global Prothrombin Complex Concentrate(PCC) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Prothrombin Complex Concentrate(PCC) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) includingcoagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding.
Prothrombin Complex Concentrate(PCC) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prothrombin Complex Concentrate(PCC) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hopistial and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prothrombin Complex Concentrate(PCC) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prothrombin Complex Concentrate(PCC) key manufacturers include CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS, Biotest, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, WEIGUANG BIOLOGICAL, Green Cross and BOHUI, etc. CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS are top 3 players and held % sales share in total in 2022.
Prothrombin Complex Concentrate(PCC) can be divided into 100IU, 200IU, 300IU and 400IU, etc. 100IU is the mainstream product in the market, accounting for % sales share globally in 2022.
Prothrombin Complex Concentrate(PCC) is widely used in various fields, such as Hopistial, Clinic and Others,, etc. Hopistial provides greatest supports to the Prothrombin Complex Concentrate(PCC) industry development. In 2022, global % sales of Prothrombin Complex Concentrate(PCC) went into Hopistial filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prothrombin Complex Concentrate(PCC) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical
Segment by Type
100IU
200IU
300IU
400IU
1000IU
Hopistial
Clinic
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prothrombin Complex Concentrate(PCC) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prothrombin Complex Concentrate(PCC), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prothrombin Complex Concentrate(PCC) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prothrombin Complex Concentrate(PCC) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prothrombin Complex Concentrate(PCC) introduction, etc. Prothrombin Complex Concentrate(PCC) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prothrombin Complex Concentrate(PCC) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Prothrombin Complex Concentrate(PCC) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prothrombin Complex Concentrate(PCC) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hopistial and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prothrombin Complex Concentrate(PCC) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prothrombin Complex Concentrate(PCC) key manufacturers include CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS, Biotest, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, WEIGUANG BIOLOGICAL, Green Cross and BOHUI, etc. CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS are top 3 players and held % sales share in total in 2022.
Prothrombin Complex Concentrate(PCC) can be divided into 100IU, 200IU, 300IU and 400IU, etc. 100IU is the mainstream product in the market, accounting for % sales share globally in 2022.
Prothrombin Complex Concentrate(PCC) is widely used in various fields, such as Hopistial, Clinic and Others,, etc. Hopistial provides greatest supports to the Prothrombin Complex Concentrate(PCC) industry development. In 2022, global % sales of Prothrombin Complex Concentrate(PCC) went into Hopistial filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prothrombin Complex Concentrate(PCC) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical
Segment by Type
100IU
200IU
300IU
400IU
1000IU
Segment by Application
Hopistial
Clinic
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prothrombin Complex Concentrate(PCC) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prothrombin Complex Concentrate(PCC), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prothrombin Complex Concentrate(PCC) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prothrombin Complex Concentrate(PCC) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prothrombin Complex Concentrate(PCC) introduction, etc. Prothrombin Complex Concentrate(PCC) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prothrombin Complex Concentrate(PCC) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices